biopharmaceutical research and development

Ascendis Pharma is a global biopharmaceutical company founded in 2007 and headquartered in Copenhagen, Denmark, with research facilities in Germany and offices across Europe and the United States. It applies its TransCon technology platform to develop therapies in Endocrinology Rare Disease and Oncology, and is publicly traded on Nasdaq (ASND).

clinical developmentdrug innovation using TransCon technology platform

Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. It focuses on CNS conditions including depression, Alzheimer's disease agitation, migraine, narcolepsy and fibromyalgia, and develops therapeutic options with novel mechanisms of action. The company was founded in January 2012 and is headquartered at One World Trade Center, New York, NY.

clinical development of CNS therapies

ENDACEA (RTP, NC) is a biopharmaceutical research and development company that has been at the forefront of biopharmaceutical R&D since 1996. Led by Constance Neely Wilson, M.D., the company outsources operations and develops innovations including a mutant plasmid cDNA for the A1 adenosine receptor as a treatment for cancer, and its lead compound A1 adenosine receptor antagonist, L-97-1, as an intravenous treatment for sepsis and acute renal failure.

drug discovery and developmentoutsourcing operationsvirtual R&D